Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI. (Q48863193)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

cerebral infarction

1 reference

based on heuristic

inferred from title

author name string

M A Yenari

1

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

J T Palmer

2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

G H Sun

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

A de Crespigny

4

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

M E Mosely

5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

G K Steinberg

6

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

language of work or name

0 references

publication date

1 November 1996

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

739

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

1-2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

36-45

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

Clinical trial of nimodipine in acute ischemic stroke. The American Nimodipine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Diffusion nuclear magnetic resonance imaging in experimental stroke. Correlation with cerebral metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

SB 201823-A Antagonizes Calcium Currents in Central Neurons and Reduces the Effects of Focal Ischemia in Rats and Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

A selective N-type Ca(2+)-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

The effect of hypothermia on transient middle cerebral artery occlusion in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists

2 references

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Glutamate neurotoxicity in cortical cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Apparent diffusion coefficient mapping of experimental focal cerebral ischemia using diffusion-weighted echo-planar imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Calcium channel antagonist peptides define several components of transmitter release in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

A controlled trial of nimodipine in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Efficacy and mechanism of action of a calcium channel blocker after global cerebral ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Nimodipine pretreatment improves cerebral blood flow and reduces brain edema in conscious rats subjected to focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Circulation of Red Blood Cells Having High Levels of 2,3-Bisphosphoglycerate Protects Rat Brain From Ischemic Metabolic Changes During Hemodilution

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Magnetic resonance imaging assessment of evolving focal cerebral ischemia. Comparison with histopathology in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Limitations of tetrazolium salts in delineating infarcted brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Reversible middle cerebral artery occlusion without craniectomy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Omega-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Multiple calcium channels and neuronal function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Diffusion and perfusion magnetic resonance imaging studies to evaluate a noncompetitive N-methyl-D-aspartate antagonist and reperfusion in experimental stroke in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Combined perfusion and diffusion-weighted magnetic resonance imaging in a rat model of reversible middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Perfusion and Diffusion-Weighted MR Imaging for In Vivo Evaluation of Treatment With U74389G in a Rat Stroke Model

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Effects of diverse omega-conopeptides on the in vivo release of glutamic and gamma-aminobutyric acids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Peptide neurotoxins from fish-hunting cone snails

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Diversity of Conus neuropeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Correlation of triphenyltetrazolium chloride perfusion staining with conventional neurohistology in the detection of early brain ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Multiple types of neuronal calcium channels and their selective modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Postischemic (1 hour) hypothermia significantly reduces ischemic cell damage in rats subjected to 2 hours of middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

The omega-conopeptide SNX-111, an N-type calcium channel blocker, dramatically ameliorates brain damage due to transient focal ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2900808-6

7 January 2021

Identifiers

10.1016/S0006-8993(96)00808-6

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/8955922

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48863193&oldid=1488667217"